Hypertension, Pulmonary: all 1,119 studies

Page 4 of 12. Open to participants first (236), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)TerminatedNCT02138825Phase 2Results posted
• Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular DysfunctionCompletedNCT02133352Phase 4Results posted
• RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter DefibrillatorsCompletedNCT02111980Not applicableResults posted
• A Multiple Dose Titration Study of MK-8892 in Participants With Pulmonary Hypertension and Left Heart Disease (MK-8892-007)TerminatedNCT02078557Phase 1Results posted
• Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular DysfunctionCompletedNCT02070991Phase 2Results posted
• Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary HypertensionCompletedNCT02060721Phase 2Results posted
• Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart FailureTerminatedNCT02053246Phase 4Results posted
• Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIATCompletedNCT02036970Phase 2Results posted
• Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High AltitudeCompletedNCT02024386Phase 4Results posted
• Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary HypertensionCompletedNCT02021292Phase 2Results posted
• Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung DiseaseCompletedNCT01948518Not applicableResults posted
• Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection FractionCompletedNCT01932606Phase 2Results posted
• 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary HypertensionCompletedNCT01917136Phase 2Results posted
• Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart FailureTerminatedNCT01910389Phase 3Results posted
• A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)TerminatedNCT01894022Phase 3Results posted
• Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension.TerminatedNCT01884675Phase 3Results posted
• Tadalafil for Pulmonary Hypertension Due to Chronic Lung DiseaseCompletedNCT01862536Phase 2Results posted
• Targeting the Right Ventricle in Pulmonary HypertensionCompletedNCT01839110Phase 4Results posted
• A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)CompletedNCT01824290Phase 3Results posted
• A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN)CompletedNCT01801982Results posted
• Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PHCompletedNCT01726049Phase 3Results posted
• A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The NewbornCompletedNCT01720524Phase 3Results posted
• Dietary Nitrate for Heart FailureCompletedNCT01682356Phase 1/2Results posted
• Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial HypertensionCompletedNCT01642407Phase 4Results posted
• Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant SuitabilityCompletedNCT01615484Not applicableResults posted
• PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)CompletedNCT01586156Not applicableResults posted
• The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy VolunteersCompletedNCT01530464Phase 1Results posted
• Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This SettingCompletedNCT01529502Phase 2Results posted
• Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary HypertensionTerminatedNCT01479010Phase 1/2Results posted
• Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)TerminatedNCT01467076Phase 2Results posted
• Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)CompletedNCT01462565Phase 4Results posted
• Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT01437878Phase 2Results posted
• Inhaled Nitrite in Subjects With Pulmonary HypertensionCompletedNCT01431313Phase 2Results posted
• Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH)CompletedNCT01416636Phase 3Results posted
• Study of Sildenafil to Treat Newborns With Persistent Pulmonary HypertensionTerminatedNCT01409031Phase 2Results posted
• Persistent Pulmonary Hypertension of the NewbornTerminatedNCT01389856Phase 3Results posted
• Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529CompletedNCT01342952Phase 2Results posted
• Efficacy and Safety of Ambrisentan in Children 8-18yrsTerminatedNCT01332331Phase 2Results posted
• Safely Change From Bosentan to Ambrisentan in Pulmonary HypertensionCompletedNCT01330108Phase 4Results posted
• Tadalafil for Sarcoidosis Associated Pulmonary HypertensionCompletedNCT01324999Phase 2/3Results posted
• Safety of SonoVue on Pulmonary HemodynamicsCompletedNCT01306292Phase 2Results posted
• A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).CompletedNCT01305252Phase 4Results posted
• The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site PainCompletedNCT01260454Phase 2Results posted
• Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label TrialCompletedNCT01224210Phase 3Results posted
• Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension PatientsTerminatedNCT01210443Phase 3Results posted
• A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension PatientsTerminatedNCT01204853Phase 3Results posted
• Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters.CompletedNCT01179334Phase 2Results posted
• A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)CompletedNCT01178073Phase 3Results posted
• A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary HypertensionCompletedNCT01104870Phase 2Results posted
• Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the NewbornTerminatedNCT01088997Not applicableResults posted
• A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging SystemCompletedNCT01076296Results posted
• Sedation With Dexmedetomidine During Cardiac CatheterizationTerminatedNCT01072643Phase 2/3Results posted
• Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)TerminatedNCT01069861Phase 2Results posted
• A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic DysfunctionTerminatedNCT01065454Phase 2Results posted
• Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation KineticsTerminatedNCT01065051Phase 2Results posted
• Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With AmbrisentanCompletedNCT01051960Phase 4Results posted
• Glutamine Therapy for Hemolysis-Associated Pulmonary HypertensionCompletedNCT01048905Phase 2Results posted
• A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic SclerosisCompletedNCT01042158Phase 4Results posted
• Anticoagulation For Pulmonary Hypertension in Sickle Cell DiseaseTerminatedNCT01036802Phase 2Results posted
• A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary HypertensionCompletedNCT01028651Results posted
• To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 WeeksCompletedNCT00946114Results posted
• BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary HypertensionCompletedNCT00910429Phase 3Results posted
• Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial HypertensionCompletedNCT00887978Phase 3Results posted
• ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary FibrosisTerminatedNCT00879229Phase 3Results posted
• Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR).CompletedNCT00878878Phase 4Results posted
• Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary HypertensionCompletedNCT00872170Phase 2/3Results posted
• BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial HypertensionCompletedNCT00863681Phase 3Results posted
• A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.CompletedNCT00855465Phase 3Results posted
• A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial HypertensionTerminatedNCT00853112Phase 2Results posted
• Safety and Efficacy Trial to Treat Diastolic Heart Failure Using AmbrisentanTerminatedNCT00840463Phase 4Results posted
• Insulin Resistance in Pulmonary Arterial HypertensionTerminatedNCT00825266Phase 2Results posted
• A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)CompletedNCT00810693Phase 3Results posted
• Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding SildenafilTerminatedNCT00796666Phase 3Results posted
• Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term SafetyTerminatedNCT00796510Phase 3Results posted
• Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)TerminatedNCT00795639Phase 3Results posted
• Study of Ambrisentan in Participants With Pulmonary HypertensionCompletedNCT00777920Phase 3Results posted
• The Role of Endothelin in Pulmonary HypertensionCompletedNCT00759408Phase 2Results posted
• Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary FibrosisTerminatedNCT00703339Phase 2Results posted
• Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan)CompletedNCT00666198Results posted
• Rapid Switch From Flolan to Remodulin in the Outpatient ClinicTerminatedNCT00643604Phase 4Results posted
• Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension.CompletedNCT00640315Phase 1Results posted
• Safety Study of Gleevec® in Children With Pulmonary HypertensionTerminatedNCT00583115Phase 2Results posted
• A Study to Evaluate GSK1325760A - a Long-Term Extension StudyCompletedNCT00554619Phase 3Results posted
• Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the LungsCompletedNCT00549302Phase 3Results posted
• Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00540436Phase 2Results posted
• Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary FibrosisCompletedNCT00517933Phase 3Results posted
• Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell DiseaseTerminatedNCT00492531Phase 2Results posted
• The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 SettingTerminatedNCT00467896Phase 2Results posted
• Using Health-related Quality of Life (HRQL) in Routine Clinical CareCompletedNCT00457301Results posted
• Open Label Study of Sildenafil in Patients With Pulmonary Arterial HypertensionCompletedNCT00454207Phase 3Results posted
• Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial HypertensionCompletedNCT00424021Phase 2Results posted
• Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial HypertensionCompletedNCT00423592Phase 2Results posted
• A Study of Aspirin and Simvastatin in Pulmonary Arterial HypertensionTerminatedNCT00384865Phase 2Results posted
• Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary HypertensionCompletedNCT00380068Phase 3Results posted
• Placebo Controlled Trial of Bosentan in Scleroderma PatientsTerminatedNCT00377455Phase 2Results posted
• Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to RemodulinCompletedNCT00373360Phase 4Results posted
• Sildenafil Study to Treat Idiopathic Pulmonary FibrosisCompletedNCT00359736Phase 2Results posted
• Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary HypertensionTerminatedNCT00350844Phase 1/2Results posted
• FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)CompletedNCT00325442Phase 3Results posted
• FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)CompletedNCT00325403Phase 3Results posted

← Hypertension, Pulmonary overview